CD44 and breast cancer: Different BC subtypes exhibit different proportions of BCSCs, subtypes TNBC and BRCA1 hereditary are enriched for cells with the stem cells phenotype (CD44+/CD24−), while HER2+ tumors contain very few cells with this phenotype [36,37].